A. Lundqvist

发表

Development of a Novel Lung Slice Methodology for Profiling of Inhaled Compounds.

Margareta Hammarlund-Udenaes, Petter Svanberg, Markus Fridén, 2016, Journal of pharmaceutical sciences.

Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs

A. Lundqvist, E. Boger, P. Ewing, 2016, CPT: pharmacometrics & systems pharmacology.

Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2013, Drug development and industrial pharmacy.

Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2011, Drug development and industrial pharmacy.

Pharmacokinetics of BX211 after oral administration of nano- and microsuspensions to rats during early development

A. Lundqvist, P. Svanberg, K. Sigfridsson, 2009 .

Development of a Highly Sensitive Method Using Liquid Chromatography-Multiple Reaction Monitoring to Quantify Membrane P-Glycoprotein in Biological Matrices and Relationship to Transport Function

T. Andersson, T. Miliotis, J. Palm, 2011, Drug Metabolism and Disposition.

Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms.

H. Lennernäs, B. Abrahamsson, E. Sjögren, 2016, Molecular pharmaceutics.

Glutathione transferase isoenzyme patterns in the rat ovary.

J. Depierre, A. Lundqvist, E. Toft, 1997, Chemico-biological interactions.

A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) mice.

I. Wilson, M. Hutchison, R. Gallagher, 2014, Biochemical pharmacology.

Dapagliflozin‐lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice

D. Baines, A. Åstrand, J. Tregoning, 2017, British journal of pharmacology.

Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study

P. Howarth, D. Shaw, P. Bakke, 2021, European Respiratory Journal.

Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma

L. Rönnblom, A. Laurence, D. Zervas, 2022, Drug design, development and therapy.

Lung pharmacokinetics of inhaled and systemic drugs: A clinical evaluation

J. Hohlfeld, O. Holz, U. Eriksson, 2021, British journal of pharmacology.

Airway Epithelial Lining Fluid and Plasma Pharmacokinetics of Inhaled Fluticasone Propionate and Salmeterol Xinafoate in Mechanically Ventilated Pigs.

A. Lundqvist, P. Ewing, AnnaMaria Péterffy, 2020, Journal of aerosol medicine and pulmonary drug delivery.

Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA.

H. Lennernäs, P. Langguth, E. Sjögren, 2017, Molecular pharmaceutics.

Regional Intestinal Permeability of Three Model Drugs in Human.

H. Lennernäs, B. Abrahamsson, P. Hellström, 2016, Molecular pharmaceutics.

Evaluating zinc content in aquatic ecosystem by estimating the responses of diatom biofilm to environmental and biological variables

A. Lundqvist, 2016 .

The effects of three absorption‐modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs

H. Lennernäs, P. Langguth, E. Sjögren, 2018, International journal of pharmaceutics.

Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2.

Yafeng Xue, F. Narjes, Marie Brännström, 2019, ACS medicinal chemistry letters.

Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development

A. Lundqvist, K. Sigfridsson, Kalle Sigfridsson, 2009, Drug development and industrial pharmacy.

Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model.

H. Lennernäs, E. Sjögren, C. Tannergren, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Effect of absorption‐modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport

H. Lennernäs, E. Sjögren, C. Tannergren, 2018, International journal of pharmaceutics.

Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor—the importance of gastrointestinal pH and solubility for the in vivo exposure

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2011, Drug development and industrial pharmacy.

Discovery of the Oral Leukotriene-C4 Synthetase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) as a New Treatment for Asthma.

L. Swedin, U. Andersson, C. Tyrchan, 2019, Journal of medicinal chemistry.

Hydroxyl Radical Reactions with Phenol as a Model for Generation of Biologically Reactive Tyrosyl Radicals

Leif A. Eriksson, L. Eriksson, A. Lundqvist, 2000 .

DDDT_A_354291 2901..2917

L. Rönnblom, A. Laurence, D. Zervas, 2022 .

Lung Retention by Lysosomal Trapping of Inhaled Drugs Can Be Predicted In Vitro With Lung Slices.

E. Bäckström, A. Lundqvist, E. Boger, 2016, Journal of pharmaceutical sciences.

Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2014, Drug development and industrial pharmacy.